Results 221 to 230 of about 24,022 (284)

Mannosylated nanocarriers: a precision targeting strategy for tumors and infectious diseases. [PDF]

Front Pharmacol
Gao B, Wang Z, Tan W.
europepmc   +1 more source

Intratumoral Microbiota in Tumor: Current Understandings and Future Perspectives

MedComm, Volume 7, Issue 7, July 2026.
Intratumoral bacteria are emerging as active regulators of cancer evolution rather than bystanders. This review outlines how tumor‐resident microbes drive tumor initiation and growth by inducing genomic instability, epigenetic reprogramming, oncogenic signaling, and chronic inflammation, while promoting metastatic spread via invasion, angiogenesis ...
Jiawei Chen, Yupan Bai, Lu Shen, Jiacheng Ying, Jie Xu, Jiayin Tang, Yujie Bao   +6 more
wiley   +1 more source

Vaccines as treatment for melanoma: an update review. [PDF]

Front Immunol
Zhang J, Cao Q, Cen Y, Zhang L, Chen J.
europepmc   +1 more source

Dynamics of Circulating Tumor DNA (ctDNA) Predict Treatment Efficacy and Prognosis in Patients With Advanced Pancreatic Cancer: A Prospective Large‐Cohort Study

MedComm, Volume 7, Issue 7, July 2026.
A total of 127 advanced pancreatic ductal adenocarcinoma (PDAC) patients receiving first‐line therapy were enrolled in this study. A series of peripheral blood collected before the initiation of treatment (B1), at the first response assessment (B2), and at subsequent timepoints to perform high‐depth next‐generation sequencing.
Tingting You, Hui Tang, Mingming Yuan, Dongfeng Song, Chenyu Wang, Jinrong Ying, Rongrong Chen, Chunmei Bai, Yuejuan Cheng, Yingyi Wang   +9 more
wiley   +1 more source

T-cell mechanisms in atopic dermatitis. [PDF]

Allergol Select
Baumann PC, Roesner LM.
europepmc   +1 more source

Metabolic Dysfunction‐Associated Fatty Liver Disease: From Pathogenesis to Treatment

MedComm, Volume 7, Issue 7, July 2026.
Extracellular vesicles play a crucial role in interorgan crosstalk of adipose–liver and gut–liver axes and hold potential as therapeutic targets and drug delivery systems for metabolic dysfunction‐associated fatty liver disease (MAFLD). Abbreviations: AT: adipose tissue; EVs: extracellular vesicles; HL: healthy liver; NAFL: nonalcoholic fatty liver ...
Zhifu Cui, Xiaxia Du, Felix Kwame Amevor, Yaoyao Xia, You Yang, Lingbin Liu   +5 more
wiley   +1 more source

Fecal Proteomics Suggest Potential Biomarkers for Non‐Alcoholic Fatty Liver Disease and Steatohepatitis

PROTEOMICS – Clinical Applications, Volume 20, Issue 4, July 2026.
ABSTRACT Background and aims Non‐alcoholic Fatty Liver Disease (NAFLD) affects about a quarter of the world's population. Liver biopsy remains the gold standard for diagnosing the progressive form of NAFLD called Non‐alcoholic Steatohepatitis (NASH) but it is invasive, prone to sampling errors and observer variability, and impractical for widespread ...
Anna Negroni, Luisa Pieroni, Noemi Fiaschini, Francesca Palone, Mariateresa Mancuso, Roberta Vitali   +5 more
wiley   +1 more source

O-glycosylation in Cancer: Emerging Paradigms and Prospects for Precision Oncology. [PDF]

Int J Biol Sci
Wei J, Hu S, Chen W, Paek HS, Liu G, Pan Y.   +5 more
europepmc   +1 more source

Transformation or Clonal Evolution? A Rare Case Report of Pulmonary Sarcomatoid Carcinoma Developing to Small Cell Lung Cancer

Thoracic Cancer, Volume 17, Issue 13, July 2026.
This is the first reported case of pulmonary sarcomatoid carcinoma undergoing conversion to small cell lung cancer. Genetic profiling of serial biopsies suggests clonal evolution or alternative transformation mechanisms. ABSTRACT Many cases of non‐small cell lung cancer (NSCLC) transforming to small cell lung cancer (SCLC) after targeted therapy have ...
Wen Jiang, Yuwei Zhang, Xingmei Li, Qi Si, Zhaohuan Ye, Youfeng Ma, Haitao Zhou, Jianwei Huang, Chao Zhang, Ge Zhang   +9 more
wiley   +1 more source

Sialylation in Thyroid Carcinoma: An Overview of Mechanisms, Markers, and Therapeutic Opportunities. [PDF]

J Cancer
Li C, Zhou J, Zhang L, Si Y, Zhang X, Shen M.   +5 more
europepmc   +1 more source